Analysis of bacterial bowel communities of IBD patients: What has it revealed?

The bacterial community, in whole or in part, resident in the bowel of humans is considered to fuel the chronic immune inflammatory conditions characteristic of Crohn's disease and ulcerative colitis. Chronic or recurrent pouchitis in ulcerative colitis patients is responsive to antibiotic therapy, indicating that bacteria are the etiological agents. Microbiological investigations of the bacterial communities in stool or of biopsy‐associated bacteria have so far failed to reveal conclusively the existence of pathogens or bacterial communities of consistently altered composition in IBD patients relative to control subjects. Confounding factors need to be eliminated from future studies by using better‐defined patient populations of newly diagnosed and untreated individuals and by improved sampling procedures.

[1]  C. Schultsz,et al.  The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. , 1999, Gastroenterology.

[2]  Stephen R. Quake,et al.  Microfluidic Digital PCR Enables Multigene Analysis of Individual Environmental Bacteria , 2006, Science.

[3]  M. Weichenthal,et al.  Inducible and Constitutive &bgr;-Defensins Are Differentially Expressed in Crohn's Disease and Ulcerative Colitis , 2003, Inflammatory bowel diseases.

[4]  M. Al-Haddad,et al.  Differentiating risk factors for acute and chronic pouchitis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  R. Bibiloni,et al.  Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent? , 2008, Journal of medical microbiology.

[6]  P. Brigidi,et al.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[7]  Hao-Ran Wu,et al.  Pouchitis and pouch dysfunction. , 2010, The Medical clinics of North America.

[8]  Gerwin C. Raangs,et al.  Variations of Bacterial Populations in Human Feces Measured by Fluorescent In Situ Hybridization with Group-Specific 16S rRNA-Targeted Oligonucleotide Probes , 1998, Applied and Environmental Microbiology.

[9]  S. Miehlke,et al.  Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. , 2006, Journal of medical microbiology.

[10]  H. Redmond,et al.  Sulfate-Reducing Bacteria Colonize Pouches Formed for Ulcerative Colitis but Not for Familial Adenomatous Polyposis , 2002, Diseases of the colon and rectum.

[11]  D. Savage.  Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.

[12]  J. Cummings,et al.  The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis , 2000, Gut.

[13]  J. Garcia-Gil,et al.  Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis , 2006, Inflammatory bowel diseases.

[14]  J. Cummings.  Short‐chain fatty acid enemas in the treatment of distal ulcerative colitis , 1997, European journal of gastroenterology & hepatology.

[15]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.

[16]  M. Weichenthal,et al.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Boyle,et al.  Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. , 1994, Gut.

[18]  H. Buhr,et al.  Mucosal and Invading Bacteria in Patients with Inflammatory Bowel Disease Compared with Controls , 2002, Scandinavian journal of gastroenterology.

[19]  N. Barnich,et al.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. , 1998, Gastroenterology.

[20]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[21]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[22]  M. Säemann,et al.  n‐Butyrate downregulates the stimulatory function of peripheral blood‐derived antigen‐presenting cells: a potential mechanism for modulating T‐cell responses by short‐chain fatty acids , 1997, Immunology.

[23]  C. Neut,et al.  Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. , 1997, Digestive diseases and sciences.

[24]  Wen-Tso Liu,et al.  Environmental microbiology-on-a-chip and its future impacts. , 2005, Trends in biotechnology.

[25]  D. Graham,et al.  Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn’s disease , 2001, Alimentary pharmacology & therapeutics.

[26]  A. Forbes,et al.  Human lymphocyte stimulation with pouchitis flora is greater than with flora from a healthy pouch but is suppressed by metronidazole , 2004, Gut.

[27]  H. Harmsen,et al.  Analysis of the Fecal Microflora of Human Subjects Consuming a Probiotic Product Containing Lactobacillus rhamnosusDR20 , 2000, Applied and Environmental Microbiology.

[28]  L. Sechi,et al.  Identification of Mycobacterium avium subsp. paratuberculosis in Biopsy Specimens from Patients with Crohn's Disease Identified by In Situ Hybridization , 2001, Journal of Clinical Microbiology.

[29]  Z. Cohen,et al.  Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis , 2001, Diseases of the colon and rectum.

[30]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[31]  James M. Becker,et al.  Colonic metaplasia in the ileal pouch is associated with inflammation and is not the result of long-term adaptation , 2003, Journal of Gastrointestinal Surgery.

[32]  S. Finegold,et al.  Effect of diet on human fecal flora: comparison of Japanese and American diets. , 1974, The American journal of clinical nutrition.

[33]  G. Tannock.  Medical importance of the normal microflora. , 1999 .

[34]  J. Wehkamp,et al.  Defensins and other antimicrobial peptides in inflammatory bowel disease , 2007, Current opinion in gastroenterology.

[35]  P. Savelkoul,et al.  Listeria monocytogenes and inflammatory bowel disease: detection of Listeria species in intestinal mucosal biopsies by real-time PCR. , 2003, Scandinavian journal of gastroenterology.

[36]  W. Selby,et al.  Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.

[37]  M. Kamm,et al.  Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis , 2006, Gut.

[38]  Yoshihide Fujiyama,et al.  Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis , 2007, Inflammatory bowel diseases.

[39]  T. Borody,et al.  Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure? , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[40]  J. G. R. Ruseler-van Embden,et al.  Anaerobic gram-negative faecal flora in patients with Crohn's Disease and healthy subjects , 1983, Antonie van Leeuwenhoek.

[41]  S. Cucchiara,et al.  Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.

[42]  S. Quake,et al.  Dissecting biological “dark matter” with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth , 2007, Proceedings of the National Academy of Sciences.

[43]  Mitsuo Sakamoto,et al.  Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. , 2005, Journal of medical microbiology.

[44]  P. Brigidi,et al.  Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial , 2000, Gastroenterology.

[45]  René Dubos,et al.  THE GASTROINTESTINAL EPITHELIUM AND ITS AUTOCHTHONOUS BACTERIAL FLORA , 1968, The Journal of experimental medicine.

[46]  S. Ahrné,et al.  Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens , 2007, Scandinavian journal of gastroenterology.

[47]  R. Newcombe,et al.  Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study. , 1998, Gut.

[48]  J. Galmiche,et al.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.

[49]  L. Augenlicht,et al.  Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. , 2003, Molecular cancer research : MCR.

[50]  K. Wilson,et al.  Ribosomal DNA Sequence Analysis of Mucosa-Associated Bacteria in Crohn’s Disease , 2004, Inflammatory bowel diseases.

[51]  Liya Su,et al.  paratuberculosis , 2022, CABI Compendium.

[52]  F. Shanahan,et al.  Bacterial DNA within Granulomas of Patients with Crohn's Disease—Detection by Laser Capture Microdissection and PCR , 2004, American Journal of Gastroenterology.

[53]  Manfred Dietel,et al.  Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.

[54]  J. Doré,et al.  Colonic Microbiota Signatures across Five Northern European Countries , 2005, Applied and Environmental Microbiology.

[55]  W. Hop,et al.  Eradication of Pathogenic Bacteria and Restoration of Normal Pouch Flora: Comparison of Metronidazole and Ciprofloxacin in the Treatment of Pouchitis , 2004, Diseases of the colon and rectum.

[56]  Rhodes,et al.  Open label trial of oral clarithromycin in active Crohn’s disease , 2000, Alimentary pharmacology & therapeutics.

[57]  R. Bibiloni,et al.  The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. , 2006, Journal of medical microbiology.

[58]  O. P. Dinnick,et al.  UNSAFE ANÆSTHETIC SUPPLY SYSTEMS , 1975, The Lancet.

[59]  G. Macfarlane,et al.  Alternative pathways for hydrogen disposal during fermentation in the human colon. , 1990, Gut.

[60]  J. Doré,et al.  Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa‐associated bacteria: A study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis , 2007, Inflammatory bowel diseases.

[61]  W. Hop,et al.  Delay of the First Onset of Pouchitis by Oral Intake of the Probiotic Strain Lactobacillus rhamnosus GG , 2004, Diseases of the colon and rectum.

[62]  J. Doré,et al.  Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut , 1999, Applied and Environmental Microbiology.

[63]  W. Sandborn.  Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. , 1994, Gastroenterology.

[64]  J. Doré,et al.  Molecular inventory of faecal microflora in patients with Crohn's disease. , 2003, FEMS microbiology ecology.

[65]  S. Ahrné,et al.  Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. , 2005, FEMS microbiology ecology.

[66]  Wangxue Chen,et al.  Detection of Listeria monocytogenes by polymerase chain reaction in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls , 2000, Journal of gastroenterology and hepatology.

[67]  S. Naser,et al.  Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[68]  C. Manichanh,et al.  Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.

[69]  L. Augenlicht,et al.  Inhibition of interferon γ signaling by the short chain fatty acid butyrate , 2003 .

[70]  A. J. Jones,et al.  At Least 1 in 20 16S rRNA Sequence Records Currently Held in Public Repositories Is Estimated To Contain Substantial Anomalies , 2005, Applied and Environmental Microbiology.

[71]  W. D. de Vos,et al.  Genetic Diversity of Viable, Injured, and Dead Fecal Bacteria Assessed by Fluorescence-Activated Cell Sorting and 16S rRNA Gene Analysis , 2005, Applied and Environmental Microbiology.

[72]  J. Valentine,et al.  Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease , 2004, The Lancet.

[73]  C. Holdsworth,et al.  The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. , 1991, Journal of medical microbiology.

[74]  V. Haroutunian,et al.  On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis , 2007, PloS one.

[75]  J. Doré,et al.  Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis , 2006, Gut.

[76]  P. Mortensen,et al.  Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. , 1995, Gut.

[77]  R. Beart,et al.  Familial adenomatous polyposis: Results following ileal pouch-anal anastomosis and ileorectostomy , 1992, Diseases of the colon and rectum.

[78]  H. Flint,et al.  Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut , 2000, Applied and Environmental Microbiology.

[79]  Daniel B. DiGiulio,et al.  Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.

[80]  Å. Danielsson,et al.  β‐Defensin‐3 and ‐4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis , 2004, Clinical and experimental immunology.

[81]  V. Mai,et al.  Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota composition , 2006, Gut.

[82]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[83]  Z. Cohen,et al.  Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. , 2001, Gastroenterology.

[84]  W. Roediger,et al.  THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE? , 1980, The Lancet.

[85]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[86]  W. Sandborn.  Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment , 1994 .

[87]  U. Gophna,et al.  Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[88]  J. Doré,et al.  Search for Localized Dysbiosis in Crohn's Disease Ulcerations by Temporal Temperature Gradient Gel Electrophoresis of 16S rRNA , 2005, Journal of Clinical Microbiology.

[89]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[90]  D. Graham,et al.  Detection of mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization , 2001, American Journal of Gastroenterology.

[91]  Shadi Sepehri,et al.  Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease , 2007, Inflammatory bowel diseases.

[92]  J. Doré,et al.  Temperature Gradient Gel Electrophoresis of Fecal 16S rRNA Reveals Active Escherichia coli in the Microbiota of Patients with Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[93]  T. Bull,et al.  Detection and Verification of Mycobacterium avium subsp. paratuberculosis in Fresh Ileocolonic Mucosal Biopsy Specimens from Individuals with and without Crohn's Disease , 2003, Journal of Clinical Microbiology.

[94]  Liping Zhao,et al.  Structural Shifts of Mucosa-Associated Lactobacilli and Clostridium leptum Subgroup in Patients with Ulcerative Colitis , 2006, Journal of Clinical Microbiology.

[95]  Shadi Sepehri,et al.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.

[96]  L. van Lieshout,et al.  Pouchitis: result of microbial imbalance? , 1994, Gut.

[97]  C. Holdsworth,et al.  Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. , 1992, Gut.

[98]  W. Moore,et al.  Special problems associated with the isolation and identification of intestinal bacteria in fecal flora studies. , 1974, The American journal of clinical nutrition.

[99]  W. Chamberlin,et al.  Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[100]  M. Weichenthal,et al.  Reduced Paneth cell α-defensins in ileal Crohn's disease , 2005 .

[101]  G. Macfarlane,et al.  Composition and Metabolic Activities of Bacterial Biofilms Colonizing Food Residues in the Human Gut , 2006, Applied and Environmental Microbiology.

[102]  A. Keshavarzian,et al.  Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[103]  J. Doré,et al.  Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. , 2001, Systematic and applied microbiology.

[104]  D. Rothenberger,et al.  Association Between Fecal Hydrogen Sulfide Production and Pouchitis , 2005, Diseases of the colon and rectum.

[105]  A. J. Jones,et al.  New Screening Software Shows that Most Recent Large 16S rRNA Gene Clone Libraries Contain Chimeras , 2006, Applied and Environmental Microbiology.

[106]  T. Miller,et al.  Stability of Methanobrevibacter smithii Populations in the Microbial Flora Excreted from the Human Large Bowel , 1983, Applied and environmental microbiology.

[107]  D. Rampton,et al.  Molecular Characterization of Rectal Mucosa‐Associated Bacterial Flora in Inflammatory Bowel Disease , 2005, Inflammatory bowel diseases.

[108]  J. Doré,et al.  Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon , 2003, Gut.

[109]  Elisabeth M Bik,et al.  Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[110]  G. Gibson,et al.  Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. , 2004, Current issues in intestinal microbiology.

[111]  M. V. M. Frcs,et al.  Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis , 2005, Digestive Diseases and Sciences.

[112]  A. Rademaker,et al.  Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. , 1997, Gut.

[113]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.